Anti-AnnexinII [ANEX 3D5/4]
Invented at University College London
3401 Reagents
Anti-CD33 [6C5/2]
Invented by Prof Paul Crocker at University of Oxford
Anti-SGII [SGII 9G3/3]
Invented by Dr Sharon Tooze at Cancer Research UK London Research Institute: Lincoln's Inn Fields
FACS
IHC
IP
WB
Antigen/Gene or Protein Targets: Secretogranin (SG II)
0
reviews
8
references
1
supplier
Anti-AnnexinI [ANEX 6E4/3]
Invented at University College London
Anti-HGF/SF [SBF5 C1.7]
Invented at University of Cambridge
ELISA
IHC
WB
Antigen/Gene or Protein Targets: Hepatocyte Growth Factor/Scatter Factor (HGF/SF)
0
reviews
2
references
1
supplier
Anti-Plasminogen [SBF1 C1.21]
Invented at University of Cambridge
ELISA
FACS
IHC
IF
IP
RIA
WB
Antigen/Gene or Protein Targets: S100A9 (MRP14)
0
reviews
4
references
1
supplier
Anti-ErbB4 [HFR1]
Invented by Bill Gullick at Imperial Cancer Research Fund
FACS
IHC
IF
IP
WB
Antigen/Gene or Protein Targets: ErbB4 (Her4, p180erbB4)
0
reviews
10
references
1
supplier
Anti-ACTR2 [149/1]
Invented by Prof Roy Bicknell at University of Oxford
IHC
IF
IP
WB
Antigen/Gene or Protein Targets: Activin receptor type 2 (ACTR2)
0
reviews
6
references
1
supplier
Page 1 of 341